SLRX
Salarius Pharmaceuticals, Inc.
Insiders bought $20K net in the last 90 days ·1 seller, 2 buyers· latest Form 4 filed Jan 2, 2026
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$17
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jan 2, 2026
HANISH ARNOLD C
Salarius Pharmaceuticals, Inc. (SLRX) has 3 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jan 2, 2026.
Inside the rolling window, 2 insiders at Salarius Pharmaceuticals, Inc. reported 2 open-market purchases totaling $20K and 1 open-market sale totaling $17. The most recent open-market filing is a sale of 27 shares by Director HANISH ARNOLD C, dated Dec 30, 2025, worth $17.
- Industry:Biotechnology
- CEO:Frederick E. Pierce
- Employees:2
- HQ:Houston, TX, US
- IPO:2015-01-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 27 | $17 | Jan 2 | — | SEC ↗ | |
HANISH ARNOLD CFirst filing | Director | Purchase | 5,000 | $4K | Nov 24 | — | SEC ↗ |
Rosenblum Mark JFirst filing | Exec VP Finance, CFO | Purchase | 20,000 | $16K | Nov 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does SLRX have?
Salarius Pharmaceuticals, Inc. (SLRX) has 3 SEC Form 4 filings (4 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jan 2, 2026.
When was the most recent SEC Form 4 filing for SLRX?
The most recent Form 4 filing for SLRX on Tracefour is dated Jan 2, 2026.
What is the net insider flow at SLRX over the last 6 months?
Over the trailing 180 days, insiders at SLRX have net bought $20K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SLRX in the current window?
Inside the rolling window, insiders at SLRX bought $20K and sold $17 based on SEC Form 4 filings.
Can I get alerts for SLRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Salarius Pharmaceuticals, Inc. (SLRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.